News

Updates on activities and accomplishments at AYOXXA

As a young and dynamic company determined to anticipate and respond to customer needs, we continue to achieve milestones, bring novel products to market, expand our partnerships, and explore use of our LUNARIS™ technology in new research areas. Follow these developments here.

Conferences

Meet AYOXXA

AYOXXA @ Cytokines 2019

The 7th Annual Meeting of the International Cytokine & Interferon Society will be held at the Hofburg Conference Centre, an international conference and event centre in the Austrian capital Vienna.

Read more

Meet AYOXXA

AYOXXA @ DGfI & SIICA 2019

The German Society for Immunology (DGfI) and Italian Society for Immunology, Clinical Immunology and Allergology (SIICA) will host their joint meeting this year in Munich from 10 – 13 September.

Read more

Meet AYOXXA

AYOXXA @ BIO Convention 2019

Every year, the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States hosts the BIO International Convention. This year features discussions and networking opportunities with over 16,000 biotech leaders from 67 countries and AYOXXA will be a part of it!

Read more

Meet AYOXXA

AYOXXA @ ARVO Annual Meeting 2019

Over 12,000 experts are convening in Vancouver, Canada, for the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), the world’s largest international eye and vision conference.

Read more

Meet AYOXXA

AYOXXA @ 13th World Immune Regulation Meeting

Hosted in beautiful Davos, Switzerland, the internationally renowned World Immune Regulation Meeting (WIRM) brings together around 600 scientists from all over the world to discuss the latest findings in immunology, from immune activation and effector functions to immune tolerance and autoimmunity.

Read more

Meet AYOXXA

AYOXXA @ 14th Annual Biomarkers Congress 2019 in Manchester

AYOXXA introduces its innovative LUNARIS™ technology to senior level attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions, all working in the biomarker space across multiple therapeutic areas worldwide.

Read more

Meet AYOXXA

AYOXXA @ 37th Annual J.P. Morgan Healthcare Conference

AYOXXA introduces its innovative LUNARIS™ platform to executives from internationally renowned pharmaceutical and biotech companies as well as to members of the investment community, meeting at the largest and most informative healthcare investment symposium in the industry from January 7 - 10, 2019 at the Westin St. Francis Hotel in San Francisco, California.

Read more

Meet AYOXXA

AYOXXA @ the "iSearch", Basic Research in Ophthalmology Meeting

iSearch is a forum for basic experimental research in ophthalmology, where new findings about signaling pathways and pathomechanisms involving immune cells of the retina are presented.

Read more

Meet AYOXXA

AYOXXA @ the 6th Annual Meeting of the International Cytokine & Interferon Society in Boston

AYOXXA will be at the epicenter of cytokine and interferon research to exhibit the LUNARIS™ platform with its growing portfolio of multiplex cytokine detection kits, and to discuss its unique advantages for basic and translational applications.

Read more

Meet AYOXXA

AYOXXA @ 3rd Annual Biomarkers Congress, San Diego

AYOXXA introduces its innovative LUNARIS™ platform to executives from internationally renowned pharmaceutical and biotech companies as well as to leading scientists from academic and government institutions, meeting in one of the most vibrant life science clusters in Southern California.

Read more

Press Reviews

Press Review

Multi-cytokine profiles inform treatment decisions

Proteomics is an indispensable tool to elucidate disease etiology. Understanding the molecular background of a disease enables the development of more effective drugs and precise, reliable diagnostics.

Read more

Press Review

June Cover Story: Deep Tech

With AYOXXA cited as one of "the hottest Southeast Asian startups in Biotech", this article is telling the story of  co-founders Andreas Schmidt & Dieter Trau: From first conceptual ideas to groundbreaking technology platform and growing AYOXXA into a  young, innovative Biotech company.

Read more

Press Review

Translational proteomics at clinical scale

Proteomics is an indispensable methodology for advancing our understanding of disease etiology and the process of drug development, particularly in the post-genome era. Today, researchers often analyze entire protein networks and translate the knowledge generated from basic research into powerful clinical approaches in medical sciences. To fully explore this complex biology, enabling tools and technologies are vital.

Read more

Press Review

Why did you name your company AYOXXA Biosystems?

Interview with Wolfgang Kintzel (Co-CEO) and Dr. Markus Zumbansen (CTO), both from AYOXXA Biosystems. Article published in German language.  

Read more

Press Review

Sandwich on beads

Cologne-based AYOXXA Biosystems counts on the simultaneous quantification of Cytokines and other biomarkers, captured by antibody-coated microbeads. Company profile authored by Sigrid März, Freelancer for Laborjournal. Read full-text company profile in German language.

Read more

Press Review

AYOXXA launches LUNARIS Protein Analysis System in Asia

Founded in 2010 as a spin-off of the National University of Singapore, AYOXXA Biosystems is one of the success stories of Singapore’s Biotech start-up community. It has since grown into a global biotech company headquartered in Cologne, Germany, and it remains focused on the development and commercialization of its proprietary technology for advanced protein analysis, LUNARIS™. AYOXXA Living Health Technologies Pte.

Read more

Press Review

Meet Rodney Turner, CEO of Multiplex Protein Analysis Company AYOXXA

BIO-Europe offers many opportunities. One of them is meeting with companies’ representatives to have a chat. In this context, we met with Rodney Turner, CEO of German company AYOXXA, which markets a technology for multiplex protein analysis.Although it may sound complicated, the technology is quite straightforward. Simply put, it is the parallel analysis of multiple proteins from one single, very small sample.

Read more

Press Review

Meet Rodney Turner, CEO of Multiplex Protein Analysis Company AYOXXA

BIO-Europe offers many opportunities. One of them is meeting with companies’ representatives to have a chat. In this context, we met with Rodney Turner, CEO of German company AYOXXA, which markets a technology for multiplex protein analysis.Although it may sound complicated, the technology is quite straightforward. Simply put, it is the parallel analysis of multiple proteins from one single, very small sample.

Read more

Press Review

Beads-on-a-Chip-Multiplex-System: Analyse kleinster Volumina (Laborpraxis)

Ayoxxa Biosystems präsentiert mit Lunaris ein Bead-basiertes Multiplex-System zur Analyse kleinster Proteinprobenvolumina.

Read more

Press Review

AYOXXA launches new beads-on-a-chip multiplex protein

AYOXXA Biosystems (Cologne, Germany) have introduced a novel system, termed LUNARIS™, which is aimed to quantify soluble inflammation and immune response markers...

Read more

Press Releases

Press Release

AYOXXA launches the new LUNARIS™ Reader designed to facilitate translational research in academic and industrial laboratories

AYOXXA Biosystems GmbH, an international biotechnology company offering a range of products and services which enable advances in translational proteomics, today announces the launch of their next generation LUNARIS™ Reader.

Read more

Press Release

AYOXXA launches LUNARIS™ Human and Mouse Chemokine Kits to explore chemokine signaling

AYOXXA Biosystems GmbH, an international biotechnology company offering a range of products and services which enable advances in translational proteomics, today announces the expansion of its catalogue of kits for fully scalable multiplex protein analysis with the introduction of LUNARIS™ Chemokine Kits for exploration of human (Human 11-Plex) and murine (Mouse-12-Plex) chemokine signaling pathways.

Read more

Press Release

AYOXXA signs research agreement in the field of ophthalmology with one of the leading pharmaceutical companies

AYOXXA Biosystems GmbH, an international biotechnology company offering a range of products and services which enable advances in translational proteomics, today announced that it has signed a research agreement with one of the leading pharmaceutical companies for the development of a series of low volume, high sensitivity multiplex protein assays intend to validate protein biomarkers in the field of ophthalmology.

Read more

Press Release

AYOXXA launches LUNARIS™ Human & Mouse 6-Plex T Cell Characterization Kits to elucidate T cell differentiation

AYOXXA Biosystems GmbH, an international biotechnology company offering a range of products and services which enable advances in translational proteomics, today announced the expansion of its catalogue of kits for fully scalable multiplex protein analysis with the introduction of LUNARISTM Human & Mouse 6-Plex T Cell Characterization Kits.

Read more

Press Release

AYOXXA launches LUNARIS™ Human 12-Plex Th17 Kit expanding its portfolio for fully scalable biomarker analysis

AYOXXA Biosystems GmbH, an international biotechnology company offering a range of products and services which enable advances in translational proteomics, today announced the expansion of its catalogue of kits for fully scalable multiplex protein analysis with the introduction of LUNARISTM Human 12-Plex Th17 Kit for the quantitative validation of soluble pro-inflammatory T helper 17 (Th17) cell-related markers.

Read more

Press Release

AYOXXA @ BIO-Europe Spring 2018 - 12th International Partnering Conference

AYOXXA Biosystems GmbH, an international biotechnology company offering a range of products and services which enable advances in translational proteomics, will participate in the upcoming BIO-Europe Spring®

Read more

Press Release

AYOXXA launches LUNARIS™ Human 11-Plex Ophthalmology Kit

For multiplexed analysis of biomarker signatures in ocular fluids including vitreous and aqueous samples. Covering: angiogenic & inflammatory factors, chemokines known to be relevant in the pathology of retinal angiogenic diseases next to VEGF, the target molecule of today’s standard of care.

Read more

Press Release

AYOXXA develops multiplex assay for stratification of sepsis patients using soluble biomarkers

AYOXXA Biosystems GmbH joined "SepsisDataNet.NRW" research project funded by EFRE and comprises a consortium of NRW companies, university hospitals and universities. Funding started in July 2017 for a period of three years.

Read more

Press Release

AYOXXA launches LUNARIS Mouse 12-Plex Th17 Kit to elucidate Th17 cell biology

LUNARIS™ Mouse 12-Plex Th17 Kit comprises highly specific reagents for the quantitative analysis of soluble markers of Th17 cell biology Kit includes the primary Th17 related cytokines involved in autoimmune disorders, immune-mediated diseases as well as asthma, allergy, cancer, microbial defense and transplantation Launch marks a further step in establishing AYOXXA’s LUNARIS™ as the technology of choice for fully scalable beads-on-a-chip multiplex

Read more

Press Release

AYOXXA introduces LUNARIS™, its advanced fully integrated low-volume beads-on-a-chip multiplex protein analysis system

AYOXXA Biosystems GmbH, an international biotechnology company, today announces the introduction of its advanced low-volume beads-on-a-chip multiplex protein analysis system. The LUNARIS™ system can be readily integrated into any laboratory routine and is optimized to provide easy-to-use, standardized workflow from sample to result.

Read more

Still have any questions? Ask us!

AYOXXA Newsletter

Be the first to know! Get regular news on AYOXXA and our products.

* The following fields are required for signing up our newsletter.

Connect with AYOXXA

Follow news and developments on these networks and platforms.